Digital Ulcers Linked to More Severe Systemic Sclerosis PDF Print E-mail
Sunday, 23 January 2011 10:46
Digital ulcers are associated with more severe systemic sclerosis (SSc) disease, including skin and lung involvement, but not with pulmonary arterial hypertension (PAH) or scleroderma renal crisis (SRC), according to research published in the January issue of Arthritis Care & Research.

Sarit Khimdas, from the University of Western Ontario in London, Canada, and colleagues analyzed data from 938 patients with SSc who participated in the Canadian Scleroderma Research Group, which collects information from SSc patients annually. Data included the presence, position, and number of digital ulcers; complications; involvement of internal organs; skin score; and results from laboratory testing.

The investigators found that 8 percent of patients currently had a digital ulcer; 44 percent had had one in the past; and 53.1 percent had digital pitting scars. In limited cutaneous SSc and diffuse cutaneous SSc subsets, digital ulcers were associated with a higher disease burden, as evidenced by higher Rodnan skin scores, hand and finger scores, and worse hand function according to the Health Assessment Questionnaire score. Digital ulcers were also linked to longer disease duration, younger age at disease onset, interstitial lung disease, and topoisomerase I antibodies. No association was seen with sex, smoking, PAH, or SRC. In diffuse cutaneous SSc, digital ulcers were associated with reduced diffusing capacity for carbon monoxide and esophageal involvement.

"In conclusion, there are some associations with digital ulcers but a surprising lack of association between digital ulcers and other manifestations of structural vasculopathy, including PAH and SRC," the authors write.

Source: DoctorsLounge. Original article can be viewed here.
 
More articles :

» The Management and Treatment of Scleroderma is Improving

Management of systemic sclerosis is likely to improve as soon as an ongoing convergence of mechanistic insights, improved understanding of clinical trial design, and interest by industry results in new treatments, according to Dr. Robert F....

» Exercise More, Worry Less

Life is full of worries. When you're battling a chronic illness, it seems almost impossible to escape nagging anxieties. When will I feel better? Will my condition worsen? When can I return to work or school?But if you exercise regularly, you will...

» 7 Tips For Balancing Rest and Activity

I wanted to help patients and my friends by sharing some helpful tips about Scleroderma, an autoimmune disease in which the body attacks itself by destroying its own cells and functions. The effects of are quite severe and can affect a patient’s...

» Cytokines in Systemic Sclerosis: Focus on IL-17

Julie Baraut, Dominique Farge, Elena Ivan-Grigore, Franck Verrecchia, and Laurence MichelSystemic sclerosis (SSc) is an autoimmune disease characterized by progressive sclerosis of the skin and internal organ dysfunction. Cytokine production and...

» Interferons As A Potential Treatment For Scleroderma

A variety of new treatments are being currently investigated and developed for the treatment of Systemic in hopes of better controlling symptoms and slowing the progression of the disease. Once such treatment is Interferons, in which recent studies...

» Bosentan May Reduce Skin Fibrosis in Scleroderma

Bosentan, which has been shown to prevent digital ulcers in, also may have beneficial effects on .In a small, prospective, open-label study, treatment with the dual endothelin receptor antagonist was associated with a significant reduction in skin...